The Global Carrier Screening Market Continues to Grow Owing To the Increased Demand from Medical Practitioners worldwide to Detect and Treat Inherited Disabilities in Children
Carrier screening checks to see if a person carrying a genetic disorder is a carrier. This is often performed as part of preconception genetic testing. A carrier screen also may be performed if a newborn is diagnosed with an abnormal condition to confirm whether parents are carriers. This screening is used to make sure that children do not carry a recessive gene that can cause health problems in the future. Carrier screening is usually performed by a genetic counselor or genetic testing laboratories. They will collect and run genetic testing samples from the patient and the relatives to see if the patient or the relatives are carriers of the disease which could cause health problems in the child. The samples may also be run to see if there is a correlation between the disease that the parents have and whether the parents or relatives have symptoms of that disease.
Market Dynamics
The
main factor driving the growth of the carrier screening market is the
increasing number of acquisitions, agreements, and mergers by the key market
players. For instance, in July 2018, Myriad Genetics, Inc. acquired Counsyl,
Inc. This acquisition is estimated to make the genetic portfolio of Myriad
genetic, Inc. more extensive. The leading biotechnology companies of the world are
trying to focus on a wider variety of inexpensive and technologically advanced
test kits for carrier screening along with solutions to manage the rapid
increase of patients diagnosed with genetic disorders. In developing nations,
the rapid rate of urbanization is resulting in various lifestyle changes, which
is impacting pregnant women during the critical pregnancy phase. Hence to
detect and treat the disorders or diseases, medical professionals worldwide are
emphasizing the use of carrier screening tests. The testing kits have also
become more affordable and advanced which is boosting the growth of the market.
This
market is distributed in five regions that include North America, Europe,
Asia-Pacific, Middle East, and Africa, and Latin America. Among these, North
America is estimated to hold a bigger share of the carrier screening market
owing to the rapid product approval by organizations such as the U.S. Food and
Drug Association (FDA) and new launches related to carrier screening in the
region. The market in Europe is also estimated to witness significant growth in
the market owing to the prevalence of key players in the region.
Competitive
Analysis
Key
players administering in the global carrier screening market include Medgenome,
Luminex Corporation, Eurofins Scientific, QIAGEN, CENTOGENE N.V., Gene by Gene,
Illumina, Inc., Myriad Genetics, Inc., Sema4, Quest Diagnostics, Thermo Fisher
Scientific, Invitae Corporation, and Fulgent Genetics.
In
June 2019, the QIAseq Expanded Carrier Screening Panel was launched by QIAGEN,
which is a German supplier of advanced technologies and samples for molecular
diagnostics. The panel supplies information about the genes and targets that
are responsible for more than 200 disease indications. Likewise, in October
2019, Sema4 announced that it is launching the Expanded Carrier Screen, which
is a test to determine the risk of genetic disorder that is inherited by
children.
Comments
Post a Comment